Clarithromycin stops lung function decline in airway-centered interstitial fibrosis. - Archive ouverte HAL Access content directly
Journal Articles Respiration Year : 2013

Clarithromycin stops lung function decline in airway-centered interstitial fibrosis.

(1) , (1) , (2) , (3) , (4) , (1) , (1)
1
2
3
4

Abstract

Airway-centered interstitial fibrosis (ACIF) is a distinct type of lung interstitial fibrosis characterized by lesions centered on the airways. Several cases reported in the literature showed little to no effect of corticosteroids and a high mortality rate in the absence of lung transplantation. No other efficient approach is described for the treatment of this type of fibrosis. We report for the first time the case of a 44-year-old patient diagnosed with ACIF on surgical lung biopsy and stabilized with clarithromycin after failure of systemic corticosteroids. We need to confirm this benefit in other patients to ascertain the anti-inflammatory effect of macrolides, which are far less harmful compared to corticosteroids or immunosuppressant drugs.

Dates and versions

inserm-00872810 , version 1 (14-10-2013)

Identifiers

Cite

Stéphane Jouneau, M. Kerjouan, S. Caulet-Maugendre, S. Guillot, C. Meunier, et al.. Clarithromycin stops lung function decline in airway-centered interstitial fibrosis.. Respiration, 2013, 85 (2), pp.156-9. ⟨10.1159/000341982⟩. ⟨inserm-00872810⟩
244 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More